Looking Glass Capital
220 East 63rd Street, New York, 10065, United States
Overview
Looking Glass seeks to invest in and support mission-driven founders during the earliest days of company building. We are most inspired by entrepreneurs solving today's biggest challenges across the themes of healthier living, human capital, and sustainability and the environment. The firm was founded in 2019 by Adam Besvinick and is headquartered in New York City.
- Total investments
- 15
- Lead investments
- 7
- Investments · 12mo
- 2
- Active investors
- 2
Sector focus
- Finance
- Financial Services
- Impact Investing
- Venture Capital
Investment portfolio
- Simuhealth
Led · Seed · Dec 2025
Founded in 2024 and based in Vancouver, Simuhealth has built an enterprise resource-planning platform that schedules simulation sessions, tracks equipment and attendance, and generates outcome and resource-usage reports for healthcare trainers. The software replaces fragmented legacy tools and manual processes, enabling hospitals and academic institutions to scale and standardize clinician training programs. Current customers include the Provincial Health Services Authority, Island Health, Interior Health, and Fraser Health. With its workflow and reporting capabilities, the company positions itself as critical infrastructure for ongoing clinical skill development and compliance. The freshly raised capital will support expansion across Canada and into the United States, where it aims to broaden its hospital and academic footprint. Although revenue figures were not disclosed, exceeding its funding target suggests early market traction. Additional non-dilutive support from Canada’s NRC-IRAP will fund deeper technical R&D as the product roadmap evolves.
- Trially AI
Participated · Seed · Sep 2025
Trially AI has built a fully integrated, HIPAA-compliant platform that tackles the biggest bottleneck in clinical research—patient recruitment. Its core products include Trially Match, which analyzes unstructured EHR data to find eligible participants; Trially Connect, where the new agentic AI assistant “Margo” engages and pre-screens those candidates; and Trially Intelligence, a pipeline radar that flags suitable trials for a given patient population. The system can identify patients with roughly 95% screening accuracy, enroll 2–6× more patients per month in complex trials, reduce screen failures by 73%, and cut manual chart-review time by 91%. One research site network reported a $4 million revenue increase within three months of deployment, and users see as much as a 10× jump in identified trial candidates. The company positions itself for physicians, research sites, CROs, and pharmaceutical sponsors needing faster, more diverse enrollment. With fresh seed funding, management plans to accelerate platform adoption across research sites, sponsors, CROs, and physician networks. Financially, Trially AI has secured $4.7 million in seed capital to fuel this next phase of growth.
- Hone Health
Participated · Series A · Jan 2025
Hone Health operates an online clinic focused on preventative and proactive longevity care, combining telemedicine, at‑home and in‑person lab testing, and physician‑directed treatment plans. Founded in 2020, the platform emphasizes hormone optimization and delivers tailored protocols based on 40+ biomarkers, with plans starting at $129/month. The company reports it has crossed 300,000 patients tested and 55,000 patients treated. Hone runs a proprietary EMR and patient data engine that has collected an extensive hormone dataset and plans to expand insights into menopause, thyroid, and longevity care. The business aims to integrate medications, supplements, lifestyle guidance, and community support to improve healthspan while prioritizing regulatory compliance and patient safety. Hone recently acquired ivee to introduce in‑home healthcare services, enabling clinicians to deliver personalized care directly in patients’ homes.
- Eli
Participated · Seed · Mar 2024
Eli Technologies builds digital infrastructure that streamlines access to incentives and financing for residential clean-energy and electrification upgrades such as solar, batteries, and heat pumps. The company focuses on helping contractors and installers, retailers, and incentive-program administrators by integrating with their workflows to reduce administrative burdens and working-capital delays. Eli has piloted its platform with customers installing more than $200M in home energy and electrification upgrades in the U.S. and says it has worked with hundreds of incentive programs. The team has formed partnerships with decarbonization nonprofits, equipment manufacturers, and incentive program administrators. Eli plans to launch a first-of-its-kind open data collaborative to establish data standards and open access to critical incentive program information. The company reports several early milestones over the past nine months as it ramps product and program integrations.
- Kinspire
Led · Seed · Jan 2023
Kinspire provides virtual pediatric occupational therapy, combining one live monthly session with a therapist, unlimited messaging, and a library of activities and trainings for parents and caregivers. The company was founded in 2020 by Robert Seigel and his sister, pediatric occupational therapist Lily Baiser, after testing a parent-supported care model with Seigel's son. Memberships cost $199 per month and include one live session; additional visits can be scheduled for $59 each. Kinspire emphasizes involving parents and caregivers between sessions to accelerate progress and fill gaps in traditional care. Services are not currently covered by insurers, though families can submit individual sessions for reimbursement; the company is focused on getting insurers to pay for its care. Management says the seed raise provided two years of cash and that the company is prioritizing sustainable growth and product focus rather than rapid expansion.